Nicole Labrosse
SVP, CHIEF FINANCIAL OFFICER · HALOZYME THERAPEUTICS, INC.
- 2025
- Feb 24, 2026
- 5
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Nicole Labrosse files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Helen Torley - $42.15M in HALO purchases and sales in the last 12 months
- Matthew L. Posard - $2.61M in HALO purchases and sales in the last 12 months
- Cortney Caudill - $1.96M in HALO purchases and sales in the last 12 months
- Bernadette Connaughton - $699K in HALO purchases and sales in the last 12 months
- Mahesh Krishnan - $548K in HALO purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Nicole Labrosse?
Nicole Labrosse is a corporate insider, tracked as SVP, CHIEF FINANCIAL OFFICER of HALOZYME THERAPEUTICS, INC. (HALO). InsiderAlpha holds 5 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
When did Nicole Labrosse last file a Form 4?
The most recent primary Form 4 on record is dated 24 February 2026, one of 5 filings going back to 2025.
Has Nicole Labrosse been buying or selling stock?
Recorded transactions: 0 open-market purchases and 4 open-market sales ($1.69M) across all tracked filings.
